Graftys: broadening indication to bone marrow lesions (BML)

Three projects supported by our foundation
30 September 2015
Intel Acquires Docea Power
31 July 2015

Graftys: broadening indication to bone marrow lesions (BML)

Extension of the CE mark for GRAFTYS® HBS and Quickset for the indication of bone marrow lesions.